MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01DA5829.7FE41B50"

Данный документ является веб-страницей в одном файле, также называемой файлом веб-архива. Если вы видите это сообщение, значит, данный браузер или редактор не поддерживает файлы веб-архива. Загрузите браузер, поддерживающий веб-архивы, например Windows® Internet Explorer®.

------=_NextPart_01DA5829.7FE41B50
Content-Location: file:///C:/6A0C1B12/UA189510102_6E72.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 14">
<meta name=3DOriginator content=3D"Microsoft Word 14">
<link rel=3DFile-List href=3D"UA189510102_6E72.files/filelist.xml">
<link rel=3DPreview href=3D"UA189510102_6E72.files/preview.wmf">
<title>Instruction</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Tanasova Zoriana</o:Author>
  <o:Keywords>approval</o:Keywords>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Bravada</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>3</o:TotalTime>
  <o:LastPrinted>2023-12-07T08:31:00Z</o:LastPrinted>
  <o:Created>2024-02-05T09:50:00Z</o:Created>
  <o:LastSaved>2024-02-05T09:50:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>1400</o:Words>
  <o:Characters>7980</o:Characters>
  <o:Company>ZF POLPHARMA S.A., Representative office  in Ukraine</o:Compan=
y>
  <o:Lines>66</o:Lines>
  <o:Paragraphs>18</o:Paragraphs>
  <o:CharactersWithSpaces>9362</o:CharactersWithSpaces>
  <o:Version>14.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DdataStoreItem href=3D"UA189510102_6E72.files/item0001.xml"
target=3D"UA189510102_6E72.files/props002.xml">
<link rel=3DthemeData href=3D"UA189510102_6E72.files/themedata.thmx">
<link rel=3DcolorSchemeMapping
href=3D"UA189510102_6E72.files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>RU</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"true"
  DefSemiHidden=3D"true" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"267">
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" QFormat=3D"true" Name=3D=
"caption"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" Name=3D"annotation refere=
nce"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" Name=3D"page number"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" Name=3D"Default Paragraph=
 Font"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtitle"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" Name=3D"Body Text 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"59" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Placeho=
lder Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Revisio=
n"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" QFormat=3D"true" Name=3D=
"TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-134238209 -371195905 63 0 4129279 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520092929 1073786111 9 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-134238209 -371195905 63 0 4129279 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;}
h5
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 5 Знак";
	mso-style-next:Обычный;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:right;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Текст примечания Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-link:"Верхний колонтитул Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 240.95pt right 17.0cm;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Нижний колонтитул Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 233.85pt right 467.75pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;}
span.MsoCommentReference
	{mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{mso-style-unhide:no;
	mso-style-link:"Основной текст 2 Знак";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	line-height:200%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;}
p
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Arial Unicode MS";}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"Текст примечания";
	mso-style-link:"Тема примечания Знак";
	mso-style-next:"Текст примечания";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Текст выноски Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-US;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParag=
raphCxSpFirst
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListPar=
agraphCxSpMiddle
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagra=
phCxSpLast
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.5
	{mso-style-name:"Заголовок 5 Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 5";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:RU;
	mso-fareast-language:RU;
	font-weight:bold;}
span.a
	{mso-style-name:"Нижний колонтитул Знак";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Нижний колонтитул";
	mso-bidi-font-size:10.0pt;
	font-family:"Arial","sans-serif";
	mso-ascii-font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Arial;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:RU;}
p.a0, li.a0, div.a0
	{mso-style-name:\00CE\00E1\0171\00F7\00ED\0171\00E9;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:PL;
	mso-fareast-language:PL;}
p.1, li.1, div.1
	{mso-style-name:"\00E7\0155\0103\00EE\00EB\00EE\00E2\00EE\0119 1";
	mso-style-unhide:no;
	mso-style-parent:\00CE\00E1\0171\00F7\00ED\0171\00E9;
	mso-style-next:\00CE\00E1\0171\00F7\00ED\0171\00E9;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:PL;
	mso-fareast-language:PL;
	font-weight:bold;}
span.2
	{mso-style-name:"Основной текст 2 Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Основной текст 2";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:RU;}
span.shorttext
	{mso-style-name:short_text;
	mso-style-unhide:no;
	mso-style-parent:"";}
span.hps
	{mso-style-name:hps;
	mso-style-unhide:no;
	mso-style-parent:"";}
span.a1
	{mso-style-name:"Текст выноски Знак";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Текст выноски";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-ascii-font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;
	mso-ansi-language:EN-US;
	mso-fareast-language:RU;}
span.a2
	{mso-style-name:"Верхний колонтитул Знак";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Верхний колонтитул";
	mso-ansi-font-size:11.0pt;
	font-family:"Arial","sans-serif";
	mso-ascii-font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Arial;
	mso-ansi-language:EN-US;
	mso-fareast-language:RU;}
span.tlid-translation
	{mso-style-name:tlid-translation;
	mso-style-unhide:no;}
span.a3
	{mso-style-name:"Текст примечания Знак";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Текст примечания";
	font-family:"Arial","sans-serif";
	mso-ascii-font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Arial;
	mso-ansi-language:EN-US;
	mso-fareast-language:RU;}
span.a4
	{mso-style-name:"Тема примечания Знак";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Тема примечания";
	font-family:"Arial","sans-serif";
	mso-ascii-font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Arial;
	mso-ansi-language:EN-US;
	mso-fareast-language:RU;
	font-weight:bold;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("UA189510102_6E72.files/header.htm") fs;
	mso-footnote-continuation-separator:url("UA189510102_6E72.files/header.htm=
") fcs;
	mso-endnote-separator:url("UA189510102_6E72.files/header.htm") es;
	mso-endnote-continuation-separator:url("UA189510102_6E72.files/header.htm"=
) ecs;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:42.55pt 42.55pt 42.55pt 70.9pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-even-footer:url("UA189510102_6E72.files/header.htm") ef1;
	mso-footer:url("UA189510102_6E72.files/header.htm") f1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:82145443;
	mso-list-type:hybrid;
	mso-list-template-ids:-666851498 -1963173118 68747267 68747269 68747265 68=
747267 68747269 68747265 68747267 68747269;}
@list l0:level1
	{mso-level-start-at:20;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:22.45pt;
	mso-level-number-position:left;
	margin-left:22.45pt;
	text-indent:-18.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.5pt;
	mso-level-number-position:left;
	margin-left:72.5pt;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.5pt;
	mso-level-number-position:left;
	margin-left:108.5pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.5pt;
	mso-level-number-position:left;
	margin-left:144.5pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:180.5pt;
	mso-level-number-position:left;
	margin-left:180.5pt;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.5pt;
	mso-level-number-position:left;
	margin-left:216.5pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.5pt;
	mso-level-number-position:left;
	margin-left:252.5pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:288.5pt;
	mso-level-number-position:left;
	margin-left:288.5pt;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.5pt;
	mso-level-number-position:left;
	margin-left:324.5pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1
	{mso-list-id:509025140;
	mso-list-type:hybrid;
	mso-list-template-ids:-1224965472 1168528732 68485123 68485125 68485121 68=
485123 68485125 68485121 68485123 68485125;}
@list l1:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2
	{mso-list-id:938411766;
	mso-list-type:hybrid;
	mso-list-template-ids:886465874 2143710298 69337091 69337093 69337089 6933=
7091 69337093 69337089 69337091 69337093;}
@list l2:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3
	{mso-list-id:1052729916;
	mso-list-type:simple;
	mso-list-template-ids:134807553;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:18.0pt;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4
	{mso-list-id:1155805809;
	mso-list-type:simple;
	mso-list-template-ids:134807553;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:18.0pt;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l5
	{mso-list-id:1693069357;
	mso-list-type:simple;
	mso-list-template-ids:134807553;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:18.0pt;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Обычная таблица";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-bidi-font-family:"Times New Roman";}
table.MsoTableGrid
	{mso-style-name:"Сетка таблицы";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:59;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-bidi-font-family:"Times New Roman";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"2049"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DRU style=3D'tab-interval:35.4pt'>

<div class=3DWordSection1>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
letter-spacing:-.05pt;mso-ansi-language:UK'>ІНСТРУКЦІЯ</span></b><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
UK'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
letter-spacing:-.1pt;mso-ansi-language:UK'>для медичного застосування </spa=
n></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>лікарського зас=
обу</span></b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-ansi-language:UK'>БІОТЕБАЛ<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-ansi-language:UK'>(BIOTEBAL) <o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'fo=
nt-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'>Склад: <=
o:p></o:p></span></i></b></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";letter-spac=
ing:
-.1pt;mso-ansi-language:UK'>діюча речовина</span></i><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";letter-spac=
ing:
-.1pt;mso-ansi-language:UK'>:</span><i style=3D'mso-bidi-font-style:normal'=
><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'> </span></i><a name=3D"_Hlk47093541"><i style=3D'mso-=
bidi-font-style:
normal'><span lang=3DEN-US style=3D'font-size:12.0pt;font-family:"Times New=
 Roman","serif"'>b</span></i></a><span
style=3D'mso-bookmark:_Hlk47093541'><i style=3D'mso-bidi-font-style:normal'=
><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>iotinum</span></i></span><span style=3D'mso-bookmark:=
_Hlk47093541'></span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
letter-spacing:-.1pt;mso-ansi-language:UK'>;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
font-size:
12.0pt;font-family:"Times New Roman","serif";letter-spacing:-.1pt;mso-ansi-=
language:
UK'>1 таблетка містить 5&nbsp;мг або 10&nbsp;мг біотину</span><span lang=3D=
UK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
UK'>;<o:p></o:p></span></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman","serif";letter-spacing:-.1pt;mso-ansi-languag=
e:
UK'>допоміжні речовини: </span></i><span lang=3DUK style=3D'font-size:12.0p=
t;
font-family:"Times New Roman","serif";letter-spacing:-.1pt;mso-ansi-languag=
e:
UK;mso-bidi-font-style:italic'>лактози </span><span lang=3DUK style=3D'font=
-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'>моногідр=
ат,
целюлоза мікрокристалічна, повідон К-30, натрію кроскармелоза, кремнію діок=
сид
колоїдний ангідрид, магнію стеарат, вода очищена.<b style=3D'mso-bidi-font-=
weight:
normal'><o:p></o:p></b></span></p>

<p class=3Da0 style=3D'text-align:justify'><b style=3D'mso-bidi-font-weight=
:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK;mso-fareast-langua=
ge:RU'><o:p>&nbsp;</o:p></span></b></p>

<p class=3Da0 style=3D'text-align:justify'><b style=3D'mso-bidi-font-weight=
:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK;mso-fareast-langua=
ge:RU'>Лікарська
форма. </span></b><span lang=3DUK style=3D'font-size:12.0pt;mso-ansi-langua=
ge:UK;
mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>Таблетки.</span><span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK;mso-bidi-font-weig=
ht:bold'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;background:white'><span cl=
ass=3Dhps><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Основні
фізико-хімічні властивості: </span></i></span><b style=3D'mso-bidi-font-wei=
ght:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-ansi-language:UK'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;background:white'><span la=
ng=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Arial Unicode MS";mso-ansi-language:UK'>5&nbsp;мг: таблетки білого або май=
же
білого кольору, круглі, двоопуклі; <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;background:white'><span la=
ng=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Arial Unicode MS";mso-ansi-language:UK'>10&nbsp;мг: таблетки білого або ма=
йже
білого кольору, круглі, двоопуклі, з гравіруванням «10» з одного боку.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'fo=
nt-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Arial=
 Unicode MS";
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><b style=3D'mso-bidi-font-weight:normal'>=
<span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Фармакотерапевтична група. </span></b><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
UK'>Прості препарати вітамінів. Біотин. Код АТХ A11Н А05.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'text-align:justify;background:white'><span la=
ng=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;background:white'><b><i><s=
pan
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Фармакологічні властивості.<o:p></o:p></span></i></b>=
</p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><i><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Фармакодинаміка=
.<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Біотин є життєво
важливою речовиною для розвитку та росту клітин. Як кофермент відіграє важл=
иву
роль у глюконеогенезі, ліпогенезі, біотрансформації пропіонатів, синтезі жи=
рних
кислот і розщепленні лейцину. Недостатність біотину може виникати при
незбалансованому харчуванні, тривалих дієтах і вживанні сирого яєчного білк=
а, при
парентеральному харчуванні, при синдромі мальабсорбції, після резекції тонк=
ого
кишечнику, у хворих, які перебувають на гемодіалізі; окрім цього, при
асоційованій з біотином множинній недостатності карбоксилаз потреба у біоти=
ні
через генетичний дефект є підвищеною. Недостатність проявляється реакцією на
шкірі та її придатках. В організмі біотин відіграє важливу роль в обміні
вуглеводів, жирів і білків і є життєво необхідним для нормального росту і
розвитку клітин. При попаданні в організм біотин діє як кофермент карбоксил=
аз,
чинить інсуліноподібну дію та бере участь у процесі глюконеогенезу (завдяки
участі в синтезі глюкокінази), у зв’язку з чим сприяє стабілізації вмісту ц=
укру
в крові, покращує функцію нервової системи. Біотин є синергістом інших
вітамінів групи В, фолієвої кислоти, пантотенової кислоти, ціанокобаламіну.=
 Є
дані про участь біотину в синтезі пуринових нуклеотидів. Біотин є також
джерелом сірки, що бере участь у синтезі білка – колагену і, таким чином,
позитивно впливає на структуру шкіри та її придатків (волосся, нігтів). <o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font=
-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'>Фармакок=
інетика.<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-top:.25pt;text-align:justify;line-heig=
ht:13.7pt;
mso-line-height-rule:exactly;mso-pagination:none;background:white;mso-layou=
t-grid-align:
none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:UK'>Всмоктування вільного біотину розпочинається вже у
верхній частині тонкої кишки. Тут молекула біотину проникає крізь стінку ки=
шки
у незміненому вигляді. Всмоктування відбувається головним чином за рахунок
дифузії. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;line-height:13.7pt;mso-lin=
e-height-rule:
exactly;mso-pagination:none;background:white;mso-layout-grid-align:none'><s=
pan
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Ступінь зв’язування біотину з білками плазми крові
становить 80&nbsp;%.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;line-height:13.7pt;mso-lin=
e-height-rule:
exactly;mso-pagination:none;background:white;mso-layout-grid-align:none'><s=
pan
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Концентрація вільного або лише слабко зв’язаного біот=
ину
в крові становить, як правило, від 200 до 1200</span><span lang=3DEN-US
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>&nbsp;</sp=
an><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>мкг/л. Біотин виводиться із сечею (від 6 до 50</span>=
<span
lang=3DEN-US style=3D'font-size:12.0pt;font-family:"Times New Roman","serif=
"'>&nbsp;</span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>мкг за добу) і калом. Біотин екскретується у незмінен=
ому
вигляді (близько 50</span><span lang=3DEN-US style=3D'font-size:12.0pt;font=
-family:
"Times New Roman","serif"'>&nbsp;</span><span lang=3DUK style=3D'font-size:=
12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>%) та у вигляді
біологічно неактивних метаболітів. Період напіввиведення залежить від дози і
становить майже 26 годин після прийому всередину 100&nbsp;мкг на 1 кілограм
маси тіла. У хворих із недостатністю біотинідази період напіввиведення після
застосування такої самої дози скорочується до 10–14 годин. <o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Біотин надходит=
ь до
організму людини з продуктів харчування, а також синтезується мікрофлорою
кишечнику. Поширений у раціоні харчування біотин здебільшого зв’язаний з
протеїном та зустрічається у вигляді біоцитину (продукти харчування тваринн=
ого
походження), який після гідролізу у тонкому кишечнику швидко реабсорбується=
. У
рослинах біотин частково представлений у вільній формі.<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'text-align:justify;line-height:13.7pt;mso-lin=
e-height-rule:
exactly;mso-pagination:none;background:white;mso-layout-grid-align:none'><b=
><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;line-height:13.7pt;mso-lin=
e-height-rule:
exactly;mso-pagination:none;background:white;mso-layout-grid-align:none'><b=
><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Клінічні характеристики.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;line-height:13.7pt;mso-lin=
e-height-rule:
exactly;mso-pagination:none;background:white;mso-layout-grid-align:none'><b=
><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Показання.</spa=
n></i></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'><o:p></o:p></sp=
an></i></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-layout-grid-align:none=
'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Лікування захворювань, спричинених дефіцитом біотину,=
 які
проявляються такими симптомами, як випадання волосся, порушення росту волос=
ся та
нігтів і їх надмірна ламкість, запалення шкіри навколо очей, носа, рота та =
вух,
а також запобігання симптомам захворювань, спричинених дефіцитом біотину, п=
ісля
того як лікар виключить інші причини.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><b><i style=3D'mso-bidi-font-style:normal=
'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><b><i style=3D'mso-bidi-font-style:normal=
'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Протипоказання. <o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:UK'>Гіперчутливість до біотину або до інших компонентів
препарату.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><b><i style=3D'mso-bidi-font-style:normal=
'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Взаємодія з іншими лікарськими засобами та інші види
взаємодій. <o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>При застосуванні
біотину з протисудомними препаратами (фенітоїн, карбамазепін, фенобарбітал,
примідон) можливе зниження концентрації біотину у плазмі крові за рахунок
збільшення його виведення з сечею. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Вальпроєва кисл=
ота
знижує активність біотинідази, знижуючи функції мітохондрій у печінці. <o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Пантотенова кис=
лота
у великих дозах конкурує з біотином, тому слід уникати їх одночасного
застосування.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Алкоголь знижує
кількість біотину в плазмі крові.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Стероїдні гормо=
ни
можуть пришвидшувати катаболізм біотину в тканинах.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Антибіотики мож=
уть
знижувати концентрацію біотину внаслідок порушення мікрофлори кишечнику.<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Білок сирого яй=
ця
містить протеїн авідин, який взаємодіє з біотином, тому слід уникати їх
одночасного прийому. Вживання великої кількості сирих яєць протягом 2–3 тиж=
нів
може спричинити дефіцит біотину. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Паління посилює
катаболізм біотину, що може призвести до недостатності та зниження ефективн=
ості
лікування.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><b><i style=3D'mso-bidi-font-style:normal=
'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Особливості застосування.<o:p></o:p></span></i></b></=
p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'>Не слід
порушувати тривалість курсу лікування, призначеного лікарем. У разі
переривчастого або дочасно припиненого лікування ефект препарату може
зменшуватись. Внаслідок доброї переносимості біотину лікування може
продовжуватися тривалий час.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><i style=3D'mso-bidi-font-style:normal'><=
span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK;mso-bidi-font-weight:bold'>Вплив на клінічні лаборатор=
ні
тести.<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK;mso-bidi-font-we=
ight:
bold'>Біотин може впливати на результати клінічних лабораторних досліджень,=
 які
ґрунтуються на взаємодії біотину та стрептавідину, що призводить до помилко=
вого
заниження або завищення результатів, залежно від виду дослідження. Ризик та=
кого
впливу вищий у дітей та пацієнтів із порушенням функції нирок, а також зрос=
тає
при збільшенні дози біотину. При інтерпретації результатів досліджень слід
враховувати можливий вплив застосування біотину пацієнтом, особливо якщо та=
кі
дані не узгоджуються із наявною клінічною картиною (наприклад, хибнопозитив=
ні
результати дослідження функції щитоподібної залози щодо хвороби Грейвса або
хибнонегативні результати аналізу рівня тропоніну у пацієнтів із інфарктом
міокарда). При плануванні клінічних лабораторних досліджень у пацієнтів, які
приймають біотин, слід попередньо проконсультуватися із відповідними
спеціалістами лабораторій. У разі коли не виключена можливість впливу біоти=
ну
на результати досліджень, необхідно використовувати альтернативні тести, як=
і не
залежать від цього чинника. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK;mso-bidi-font-we=
ight:
bold'>Для мінімізації впливу біотину на результати лабораторних тестів
лікарський засіб слід відмінити за 3 доби до тестування, якщо лабораторія не
вказала іншого терміну. <span style=3D'mso-spacerun:yes'> </span><b><i
style=3D'mso-bidi-font-style:normal'><o:p></o:p></i></b></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New R=
oman","serif";
mso-ansi-language:UK;mso-bidi-font-weight:bold'>Допоміжні речовини<o:p></o:=
p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:UK;mso-bidi-font-weight:bold'>1 таблетка по 5</span><span
lang=3DEN-US style=3D'font-size:12.0pt;font-family:"Times New Roman","serif=
";
mso-bidi-font-weight:bold'>&nbsp;</span><span lang=3DUK style=3D'font-size:=
12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK;mso-bidi-font-we=
ight:
bold'>мг містить 53,9&nbsp;мг лактози моногідрату, 1 таблетка по 10</span><=
span
lang=3DEN-US style=3D'font-size:12.0pt;font-family:"Times New Roman","serif=
";
mso-bidi-font-weight:bold'>&nbsp;</span><span lang=3DUK style=3D'font-size:=
12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK;mso-bidi-font-we=
ight:
bold'>мг містить 107,8&nbsp;мг лактози моногідрату. Тому пацієнтам з рідкіс=
ними
спадковими формами непереносимості галактози, недостатністю лактази або
синдромом глюкозо-галактозної мальабсорбції не слід застосовувати препарат.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:UK;mso-bidi-font-weight:bold'>Лікарський засіб вважається=
 вільним
від натрію, оскільки в одній таблетці міститься менше ніж 1&nbsp;ммоль натр=
ію
(23&nbsp;мг).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:UK;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-ansi-language:UK'>Застосування у період вагітності або годування груддю=
<span
style=3D'mso-bidi-font-style:italic'>. <o:p></o:p></span></span></i></p>

<p class=3DMsoNormal style=3D'margin-right:.95pt;text-align:justify;line-he=
ight:
13.9pt;mso-line-height-rule:exactly;mso-pagination:none;background:white;
mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-ansi-language:UK'>Кількість біотину у лікарсь=
кому
засобі Біотебал перевищує рекомендовану добову дозу для вагітних. Застосува=
ння
високих доз біотину у вагітних не досліджувалось. Лікарський засіб не слід
застосовувати у період вагітності.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:UK'>Кількість біотину у лікарському засобі Біотебал перев=
ищує
рекомендовану добову дозу для жінок, які годують груддю. Біотин виводиться з
грудним молоком, але не спостерігається впливу на грудне вигодовування. Лік=
арський
засіб не слід застосовувати у період годування груддю.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New R=
oman","serif";
mso-ansi-language:UK;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></i=
></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New R=
oman","serif";
mso-ansi-language:UK;mso-bidi-font-weight:bold'>Здатність впливати на швидк=
ість
реакції при керуванні автотранспортом або іншими механізмами. <o:p></o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:UK'>Не впливає.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><b><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'><o:p>&nb=
sp;</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><b><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'>Спосіб
застосування та дози. <o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'>Препарат
Біотебал призначений для перорального застосування дорослим. Приймати до їд=
и,
запиваючи достатньою кількістю води (наприклад, половина склянки).<span
style=3D'mso-bidi-font-weight:bold'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-layout-grid-align:none=
'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK;mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>=
Добова
доза становить 5 мг, при виражених симптомах – 10 мг.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'>Триваліс=
ть
курсу лікування залежить від характеру та перебігу захворювання і зазвичай
становить 4 тижні.</span><span lang=3DUK style=3D'font-size:12.0pt;font-fam=
ily:
"Times New Roman","serif";mso-ansi-language:RU'> </span><span style=3D'font=
-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:RU'>Полегшен=
ня
симптомів спостерігається приблизно через 4 тижні застосування.<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font=
-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'>Діти. </=
span></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:UK'>У зв’язку з обмеженим досвідом застосування препарат =
не призначають
дітям віком до 12 років. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:UK'>Дітям віком від 12 років препарат застосовують за
призначенням лікаря; рекомендації щодо дозування препарату відсутні через
обмеженість відповідних даних.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:13.7pt;text-align:justify;line-hei=
ght:
13.7pt;mso-line-height-rule:exactly;mso-pagination:none;background:white;
mso-layout-grid-align:none'><b><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Передозування. <o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>На сьогодні нем=
ає
повідомлень щодо передозування біотину.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><b><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'><o:p>&nbsp;</o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><b><i style=3D'mso-bidi-font-style:normal=
'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Побічні реакції. <o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><i><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>З боку імунної
системи:</span></i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"T=
imes New Roman","serif";
mso-ansi-language:UK'> дуже рідко (&#706;&nbsp;1/10000) спостерігаються
алергічні реакції, включаючи кропив’янку.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>У разі виникнен=
ня
будь-яких небажаних реакцій рекомендовано припинити лікування та звернутися=
 до
лікаря.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
UK'>Повідомлення про підозрювані побічні реакції.</span></i><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'>Повідомл=
ення
про підозрювані побічні реакції після реєстрації лікарського засобу відігра=
ють
важливу роль. Це дає змогу продовжувати спостереження за співвідношенням
користі та ризику застосування лікарського засобу. Працівники галузі охорони
здоров’я повинні повідомляти про будь-які підозрювані побічні реакції.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'><o:p>&nb=
sp;</o:p></span></p>

<b><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-si=
ze:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU;mso-bidi-language:AR-SA'><br
clear=3Dall style=3D'mso-special-character:line-break;page-break-before:alw=
ays'>
</span></i></b>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><b><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'><o:p>&nb=
sp;</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><b><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'>Термін
придатності.</span></i></b><i style=3D'mso-bidi-font-style:normal'><span la=
ng=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
UK'> <o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:UK'>2 роки.<b><o:p></o:p></b></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><b><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New R=
oman","serif";
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><b><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New R=
oman","serif";
mso-ansi-language:UK'>Умови зберігання. <o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:UK'>Зберігати в оригінальній упаковці при температурі не =
вище
25 °С. Зберігати у недоступному для дітей місці.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><b style=3D'mso-bidi-font-weight:normal'>=
<span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><b style=3D'mso-bidi-font-weight:normal'>=
<span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Упаковка. <o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><i><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Таблетки по 5 м=
г:<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>По </span><span
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
RU'>30</span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times N=
ew Roman","serif";
mso-ansi-language:UK'> таблеток у блістері; по </span><span style=3D'font-s=
ize:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:RU'>1</span>=
<span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>, </span><span style=3D'font-size:12.0pt;font-family:=
"Times New Roman","serif";
mso-ansi-language:RU'>2</span><span lang=3DUK style=3D'font-size:12.0pt;fon=
t-family:
"Times New Roman","serif";mso-ansi-language:UK'> або </span><span
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
RU'>3 </span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times N=
ew Roman","serif";
mso-ansi-language:UK'>блістери у картонній коробці.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><i><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Таблетки по 10 =
мг:<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>По 15 таблеток у
блістері; по 2, 4 або 6 блістерів у картонній коробці.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>По 20 таблеток у
блістері; по 6 блістерів у картонній коробці.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><b style=3D'mso-bidi-font-weight:normal'>=
<span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><b style=3D'mso-bidi-font-weight:normal'>=
<span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:UK'>Категорія відпуску.</span></b><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
UK'> <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;backgr=
ound:
white;mso-layout-grid-align:none'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:UK'>Без рецепта.<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><b style=3D'mso-bidi-font-w=
eight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'background:white'><b style=3D'mso-bidi-font-w=
eight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-ansi-language:UK'>Виробник.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK'>Фармацев=
тичний
завод <span style=3D'mso-bidi-font-weight:bold'>«</span>ПОЛЬФАРМА<span
style=3D'mso-bidi-font-weight:bold'>»</span>&nbsp;С.А. <o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:UK;mso-bidi-=
font-weight:
bold'>Pharmaceutical<span style=3D'letter-spacing:2.65pt'> </span>Works<span
style=3D'letter-spacing:2.05pt'> </span>«POLPHARMA»<span style=3D'letter-sp=
acing:
1.45pt'>&nbsp;</span>S.A.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><b style=3D'mso-bidi-font-w=
eight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'background:white'><b style=3D'mso-bidi-font-w=
eight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-ansi-language:UK'>Місцезнаходження виробника та його адреса місця прова=
дження
діяльності. <o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'font-size:12.0pt;font-family:=
"Times New Roman","serif";
mso-ansi-language:UK'>вул. Пельплиньска 19,<span class=3DMsoCommentReferenc=
e><span
style=3D'mso-ansi-font-size:12.0pt;mso-bidi-font-size:12.0pt'>&nbsp;</span>=
</span>83-200,<span
class=3DMsoCommentReference><span style=3D'mso-ansi-font-size:12.0pt;mso-bi=
di-font-size:
12.0pt'>&nbsp;</span></span>Старогард Гданьски,<span class=3DMsoCommentRefe=
rence><span
style=3D'mso-ansi-font-size:12.0pt;mso-bidi-font-size:12.0pt'>&nbsp;</span>=
</span>Польща
<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'font-size:12.0pt;font-family:=
"Times New Roman","serif";
mso-ansi-language:UK;mso-bidi-font-weight:bold'>19,&nbsp;Pelplinska<span
style=3D'letter-spacing:2.1pt'> </span>Str.,&nbsp;83-200<span style=3D'lett=
er-spacing:
.95pt'> </span>Starogard<span style=3D'letter-spacing:2.15pt'> </span>Gdans=
ki,
Poland.</span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times =
New Roman","serif";
mso-fareast-font-family:Arial;mso-ansi-language:UK'> <o:p></o:p></span></p>

</div>

</body>

</html>

------=_NextPart_01DA5829.7FE41B50
Content-Location: file:///C:/6A0C1B12/UA189510102_6E72.files/preview.wmf
Content-Transfer-Encoding: base64
Content-Type: image/x-wmf
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------=_NextPart_01DA5829.7FE41B50
Content-Location: file:///C:/6A0C1B12/UA189510102_6E72.files/item0001.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<b:Sources SelectedStyle=3D"\APA.XSL" StyleName=3D"APA" xmlns:b=3D"http://s=
chemas.openxmlformats.org/officeDocument/2006/bibliography" xmlns=3D"http:/=
/schemas.openxmlformats.org/officeDocument/2006/bibliography"></b:Sources>

------=_NextPart_01DA5829.7FE41B50
Content-Location: file:///C:/6A0C1B12/UA189510102_6E72.files/props002.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{5D0032A5-9EAD-4F27-8099-B36AD9B5C4FC}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01DA5829.7FE41B50
Content-Location: file:///C:/6A0C1B12/UA189510102_6E72.files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01DA5829.7FE41B50
Content-Location: file:///C:/6A0C1B12/UA189510102_6E72.files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01DA5829.7FE41B50
Content-Location: file:///C:/6A0C1B12/UA189510102_6E72.files/header.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 14">
<meta name=3DOriginator content=3D"Microsoft Word 14">
<link id=3DMain-File rel=3DMain-File href=3D"../UA189510102_6E72.htm">
<![if IE]>
<base href=3D"file:///C:\6A0C1B12\UA189510102_6E72.files\header.htm"
id=3D"webarch_temp_base_tag">
<![endif]><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"2049"/>
</xml><![endif]-->
</head>

<body lang=3DRU>

<div style=3D'mso-element:footnote-separator' id=3Dfs>

<p class=3DMsoNormal><span lang=3DEN-US><span style=3D'mso-special-characte=
r:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footnote-continuation-separator' id=3Dfcs>

<p class=3DMsoNormal><span lang=3DEN-US><span style=3D'mso-special-characte=
r:footnote-continuation-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-separator' id=3Des>

<p class=3DMsoNormal><span lang=3DEN-US><span style=3D'mso-special-characte=
r:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-continuation-separator' id=3Decs>

<p class=3DMsoNormal><span lang=3DEN-US><span style=3D'mso-special-characte=
r:footnote-continuation-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footer' id=3Def1>

<div style=3D'mso-element:frame;mso-element-wrap:around;mso-element-anchor-=
vertical:
paragraph;mso-element-anchor-horizontal:margin;mso-element-left:right;
mso-element-top:.05pt;mso-height-rule:exactly'>

<table cellspacing=3D0 cellpadding=3D0 hspace=3D0 vspace=3D0 align=3Dright>
 <tr>
  <td valign=3Dtop align=3Dleft style=3D'padding-top:0cm;padding-right:0cm;
  padding-bottom:0cm;padding-left:0cm'>
  <p class=3DMsoFooter style=3D'mso-element:frame;mso-element-wrap:around;
  mso-element-anchor-vertical:paragraph;mso-element-anchor-horizontal:margi=
n;
  mso-element-left:right;mso-element-top:.05pt;mso-height-rule:exactly'><!-=
-[if supportFields]><span
  class=3DMsoPageNumber><span lang=3DEN-US style=3D'font-family:"Arial","sa=
ns-serif";
  mso-bidi-font-family:"Times New Roman"'><span style=3D'mso-element:field-=
begin'></span>PAGE<span
  style=3D'mso-spacerun:yes'>  </span></span></span><![endif]--><!--[if sup=
portFields]><span
  class=3DMsoPageNumber><span lang=3DEN-US style=3D'font-family:"Arial","sa=
ns-serif";
  mso-bidi-font-family:"Times New Roman"'><span style=3D'mso-element:field-=
end'></span></span></span><![endif]--><span
  class=3DMsoPageNumber><span lang=3DEN-US style=3D'font-family:"Arial","sa=
ns-serif";
  mso-bidi-font-family:"Times New Roman"'><o:p></o:p></span></span></p>
  </td>
 </tr>
</table>

</div>

<p class=3DMsoFooter style=3D'margin-right:18.0pt'><span lang=3DEN-US><o:p>=
&nbsp;</o:p></span></p>

</div>

<div style=3D'mso-element:footer' id=3Df1>

<p class=3DMsoFooter align=3Dright style=3D'text-align:right'><!--[if suppo=
rtFields]><span
lang=3DEN-US><span style=3D'mso-element:field-begin'></span>PAGE<span
style=3D'mso-spacerun:yes'>   </span>\* MERGEFORMAT<span style=3D'mso-eleme=
nt:field-separator'></span></span><![endif]--><span
style=3D'mso-ansi-language:RU;mso-no-proof:yes'>1</span><!--[if supportFiel=
ds]><span
lang=3DEN-US><span style=3D'mso-element:field-end'></span></span><![endif]-=
-></p>

</div>

</body>

</html>

------=_NextPart_01DA5829.7FE41B50
Content-Location: file:///C:/6A0C1B12/UA189510102_6E72.files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../UA189510102_6E72.htm"/>
 <o:File HRef=3D"preview.wmf"/>
 <o:File HRef=3D"item0001.xml"/>
 <o:File HRef=3D"props002.xml"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"header.htm"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01DA5829.7FE41B50--
